Baxter International Inc.

NYSE:BAX   3:59:59 PM EDT
81.76
+0.40 (+0.49%)
Products

Baxter Announces U.S. FDA Approval And Launch Of Ready-To-Use Cardiovascular Medicine Norepinephrine In Premix Formulation

Published: 09/23/2021 13:14 GMT
Baxter International Inc. (BAX) - Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation.